OMBURTAMAB I-131
UNII B6PMV8U3C4

Substance Identification & Data

This profile provides standardized clinical and technical data for Omburtamab I-131, uniquely identified by the FDA Unique Ingredient Identifier (UNII) B6PMV8U3C4.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
B6PMV8U3C4
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
OMBURTAMAB I-131
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Omburtamab I-131. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

131-I-8H9 MONOCLONAL ANTIBODY
131I-BURTOMAB
131I-OMBURTOMAB
BURTOMAB I-131
IODINE (131I) OMBURTAMAB
IODINE (131I) OMBURTAMAB [WHO-DD]
IODINE I 131 MONOCLONAL ANTIBODY 8H9
MOUSE MAB ANTI-B7-H3 CONJUGATED TO IODINE 131
OMBURTAMAB I-131